LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway

被引：15
|
作者：
Li, Jiandong [1 ]
Xu, Xiaohu [1 ]
Zhang, Dandan [1 ]
Lv, Han [1 ]
Lei, Xin [1 ]
机构：
[1] Shenzhen Longhua Dist Cent Hosp, Dept Stomatol, Shenzhen 518000, Peoples R China
来源：
ONCOTARGETS AND THERAPY | 2021年 / 14卷
关键词：
oral squamous cell carcinoma; LHFPL3-AS1; miR-362-5p; CHSY1; CANCER METASTASIS; PROLIFERATION; INVASION; AXIS;
D O I：
10.2147/OTT.S298679
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background: Oral squamous cell carcinoma (OSCC) is a common oral cancer. The current study aims to elucidate the potential roles of long noncoding RNA (lncRNA) LHFPL3-AS1 in OSCC development. Methods: Gene expression was measured by qRT-PCR in tumor tissues and cell lines. Loss-of-function assays were performed to analyze the effects of LHFPL3-AS1 on malignant behaviors. Bioinformatics analysis was conducted to explore the downstream signaling pathway of LHFPL3-AS1 in OSCC. Results: LHFPL3-AS1 was highly expressed in OSCC tissues and cell lines. LHFPL3-AS1 was upregulated in cisplatin-resistant tumor cell lines. LHFPL3-AS1 level was correlated with survival rate. LHFPL3-AS1 knockdown suppressed OSCC proliferation, migration and invasion. LHFPL3-AS1 downregulation reduced cisplatin resistance of OSCC cells. LHFPL3-AS1 was the competing endogenous RNA (ceRNA) for miR-194-5p to enhance CHSY1 expression. Conclusion: LHFPL3-AS1/miR-362-5p/CHSY1 signaling pathway plays essential roles in regulating OSCC development and cisplatin resistance.
引用
收藏
页码：2293 / 2300
页数：8
相关论文
共 50 条
  • [1] LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p
    Ma, S-Q
    Wang, Y-C
    Li, Y.
    Li, X-Y
    Yang, J.
    Sheng, Y-M
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06) : 1993 - 2001
  • [2] lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p
    Hou, Chao
    Wang, Xu
    Du, Bo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) : 978 - 984
  • [3] LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p
    Zhang, Yuchao
    Wang, Feng
    Yu, Yang
    ORAL DISEASES, 2023, 29 (04) : 1505 - 1512
  • [4] Hsa_circ_0005050 regulated the progression of oral squamous cell carcinoma via miR-487a-3p/CHSY1 axis
    Chen, Xubin
    Chen, Qiaojiang
    Zhao, Chen
    Lu, Zhiqi
    JOURNAL OF DENTAL SCIENCES, 2023, 18 (01) : 282 - 294
  • [5] miR-379-5p regulates the proliferation, cell cycle, and cisplatin resistance of oral squamous cell carcinoma cells by targeting ROR1
    Meng, Lei
    Du, Yanlin
    Deng, Banglian
    Duan, Yinzhong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (03): : 1626 - 1639
  • [6] LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
    Fang, Zheng
    Zhao, Junfang
    Xie, Weihong
    Sun, Qiang
    Wang, Haibin
    Qiao, Bin
    CANCER MEDICINE, 2017, 6 (12): : 2897 - 2908
  • [7] miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1
    Li, Nan
    Nan, Chuan-Chuan
    Zhong, Xue-Yun
    Weng, Jun-Quan
    Fan, Hai-Dong
    Sun, Hai-Peng
    Tang, Su
    Shi, Lei
    Huang, Sheng-Xing
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (04) : 1329 - 1341
  • [8] MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI
    Wei, Xiaosong
    Wang, Beibei
    Wang, Qi
    Yang, Xiaoming
    Yang, Yang
    Fang, Zhiwei
    Yi, Chengzhi
    Shi, Lei
    Fan, Xin
    Tao, Jin
    Guo, Yufeng
    Song, Dongkui
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [9] LncRNA FERIL4 Promotes Oral Squamous Cell Carcinoma Progression via Targeting miR-133a-5p/Prx1 Axis
    Zhang, Nan
    Zeng, Lingfang
    Wang, Shouyi
    Wang, Ronghua
    Yang, Rui
    Jin, Zuolin
    Tao, Hong
    ONCOTARGETS AND THERAPY, 2021, 14 : 795 - 806
  • [10] LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma
    Wang, Fang
    Ji, Xin
    Wang, Jingjing
    Ma, Xiangrui
    Yang, Yong
    Zuo, Jinhua
    Cui, Jun
    ONCOTARGETS AND THERAPY, 2020, 13 : 243 - 252
12345